IS5878A - Powder for lungs - Google Patents

Powder for lungs

Info

Publication number
IS5878A
IS5878A IS5878A IS5878A IS5878A IS 5878 A IS5878 A IS 5878A IS 5878 A IS5878 A IS 5878A IS 5878 A IS5878 A IS 5878A IS 5878 A IS5878 A IS 5878A
Authority
IS
Iceland
Prior art keywords
lungs
powder
Prior art date
Application number
IS5878A
Other languages
Icelandic (is)
Inventor
Clark Andrew
Kuo Mei-Chang
Lalor Cecily
John Aldous Barry
Original Assignee
Nektar Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics filed Critical Nektar Therapeutics
Publication of IS5878A publication Critical patent/IS5878A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
IS5878A 1998-09-14 2001-03-05 Powder for lungs IS5878A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14
PCT/US1999/021109 WO2000015262A1 (en) 1998-09-14 1999-09-13 Dry powder active agent pulmonary delivery

Publications (1)

Publication Number Publication Date
IS5878A true IS5878A (en) 2001-03-05

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5878A IS5878A (en) 1998-09-14 2001-03-05 Powder for lungs

Country Status (44)

Country Link
EP (1) EP1117442A1 (en)
JP (1) JP2002524535A (en)
KR (1) KR20010075063A (en)
CN (1) CN1317977A (en)
AP (1) AP1374A (en)
AR (1) AR022090A1 (en)
AU (1) AU753014B2 (en)
BG (1) BG105430A (en)
BR (1) BR9913722A (en)
CA (1) CA2343920A1 (en)
CO (1) CO5130023A1 (en)
CZ (1) CZ2001829A3 (en)
DZ (1) DZ2892A1 (en)
EA (1) EA003476B1 (en)
EE (1) EE200100151A (en)
GE (1) GEP20043257B (en)
GT (1) GT199900156A (en)
HK (1) HK1042231A1 (en)
HN (1) HN1999000159A (en)
HR (1) HRP20010189A2 (en)
HU (1) HUP0103837A3 (en)
ID (1) ID28845A (en)
IL (2) IL141562A0 (en)
IS (1) IS5878A (en)
LT (1) LT4897B (en)
LV (1) LV12658B (en)
MA (1) MA25590A1 (en)
MY (1) MY129282A (en)
NO (1) NO20011251L (en)
NZ (1) NZ510168A (en)
OA (1) OA11781A (en)
PA (1) PA8481901A1 (en)
PE (1) PE20001061A1 (en)
PL (1) PL195574B1 (en)
SA (1) SA99200718B1 (en)
SK (1) SK3442001A3 (en)
TN (1) TNSN99173A1 (en)
TR (1) TR200101182T2 (en)
TW (1) TWI226248B (en)
UA (1) UA76085C2 (en)
UY (1) UY25711A1 (en)
WO (1) WO2000015262A1 (en)
YU (1) YU24201A (en)
ZA (1) ZA200101995B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4874483B2 (en) 1999-06-09 2012-02-15 ロバート イー. シーバース Supercritical fluid assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
JP2005503425A (en) * 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション Delivery of drug ester by the prescribed inhalation route
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
JP2005518453A (en) 2002-02-25 2005-06-23 ディフュージョン・ファーマシューティカルズ・エルエルシー Bipolar trans carotenoid salts and their use
AU2003232081B2 (en) * 2002-07-03 2009-02-05 Brandeis University Central airway administration for systemic delivery of therapeutics
CA2511385A1 (en) * 2002-12-19 2004-07-22 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
DE10338403A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
AU2005237523A1 (en) 2004-04-23 2005-11-10 Cydex Pharmaceuticals, Inc. DPI formulation containing sulfoalkyl ether cyclodextrin
EP2540696B1 (en) 2005-02-24 2020-01-01 Diffusion Pharmaceuticals LLC Trans carotenoids, formulation and uses
CN101171023A (en) * 2005-03-09 2008-04-30 小野药品工业株式会社 Particle and preparation containing the particle
DK2952197T3 (en) 2005-10-26 2017-08-07 Cydex Pharmaceuticals Inc SULPHALYCYLETER CYCLE CODE EXTRACTION COMPOSITION AND PROCEDURE FOR PREPARING THEREOF
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
WO2008021451A2 (en) * 2006-08-14 2008-02-21 Aktiv-Dry Llc Human-powered dry powder inhaler and dry powder inhaler compositions
EP2095812A4 (en) * 2006-10-25 2011-07-13 Dainippon Sumitomo Pharma Co Granular preparation prevented from caking
EP1925295A1 (en) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stable powder formulation containing a new antichinolinergic agent
KR101570131B1 (en) 2007-04-13 2015-11-18 디퓨젼 파마슈티컬즈 엘엘씨 Use of Bipolar Trans Carotenoids as a Pretreatment and in the Treatment of Peripheral Vascular Disease
JP2011502125A (en) 2007-10-31 2011-01-20 ディフュージョン・ファーマシューティカルズ・エルエルシー A new class of treatments that promote small molecule diffusion
PL2432502T3 (en) 2009-05-20 2018-05-30 Aeras Stable, spray dried, immunogenic, viral compositions
EP2445339B1 (en) 2009-06-22 2019-08-07 Diffusion Pharmaceuticals LLC Diffusion enhancing compound and its use with a thrombolytic
CN105287473A (en) 2010-06-02 2016-02-03 扩散药品有限公司 Oral formulations of bipolar trans carotenoids and uses thereof
RU2650636C2 (en) 2012-05-03 2018-04-16 Янссен Сайенсиз Айрлэнд Юси Polyinosinic-polycytidylic acid (poly(i:c)) formulations for the treatment of upper respiratory tract infections
BR112015010601B1 (en) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION
US20180043585A9 (en) * 2013-09-20 2018-02-15 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
EP3212212B1 (en) 2014-10-31 2020-09-23 Monash University Powder formulation
WO2017165667A1 (en) 2016-03-24 2017-09-28 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
ES2177544T3 (en) * 1992-06-12 2002-12-16 Teijin Ltd ULTRAFININE POWDER TO INHALATE AND METHOD FOR PREPARATION.
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
WO1998031346A1 (en) * 1997-01-16 1998-07-23 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
AP2001002093A0 (en) 2001-03-31
BG105430A (en) 2001-12-29
WO2000015262A1 (en) 2000-03-23
ZA200101995B (en) 2002-03-11
CO5130023A1 (en) 2002-02-27
AP1374A (en) 2005-02-28
AR022090A1 (en) 2002-09-04
EA003476B1 (en) 2003-06-26
YU24201A (en) 2003-08-29
ID28845A (en) 2001-07-05
CN1317977A (en) 2001-10-17
EA200100300A1 (en) 2001-10-22
KR20010075063A (en) 2001-08-09
GEP20043257B (en) 2004-06-25
LV12658A (en) 2001-05-20
IL141562A (en) 2007-07-24
HK1042231A1 (en) 2002-08-09
SA99200718B1 (en) 2006-11-04
PE20001061A1 (en) 2000-10-08
EP1117442A1 (en) 2001-07-25
MA25590A1 (en) 2002-12-31
LT2001021A (en) 2001-11-26
MY129282A (en) 2007-03-30
HUP0103837A3 (en) 2002-11-28
AU753014B2 (en) 2002-10-03
BR9913722A (en) 2001-05-29
UA76085C2 (en) 2006-07-17
GT199900156A (en) 2001-03-07
SK3442001A3 (en) 2001-11-06
NO20011251L (en) 2001-04-17
LT4897B (en) 2002-02-25
CZ2001829A3 (en) 2001-09-12
UY25711A1 (en) 1999-11-17
NZ510168A (en) 2003-09-26
DZ2892A1 (en) 2003-12-15
NO20011251D0 (en) 2001-03-13
IL141562A0 (en) 2002-03-10
JP2002524535A (en) 2002-08-06
EE200100151A (en) 2002-06-17
AU6039799A (en) 2000-04-03
PA8481901A1 (en) 2002-04-25
PL195574B1 (en) 2007-10-31
TWI226248B (en) 2005-01-11
CA2343920A1 (en) 2000-03-23
PL346768A1 (en) 2002-02-25
HUP0103837A2 (en) 2002-05-29
LV12658B (en) 2001-09-20
HRP20010189A2 (en) 2005-04-30
HN1999000159A (en) 1999-11-11
OA11781A (en) 2005-07-26
TR200101182T2 (en) 2001-09-21
TNSN99173A1 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
IS5878A (en) Powder for lungs
EE04707B1 (en) Powder inhaler
ATE485812T1 (en) PRESSURE-DOSE INHALERS
NO990272L (en) Powder inhaler
ID24472A (en) MAKING POWDER AGLOMERATE
IS5487A (en) inhaler
ATE321483T1 (en) CAN
DE69920824D1 (en) INHALATION APPARATUS
DE69922643D1 (en) tracheostomy
ID18427A (en) POWDER POWDER
DK1070058T3 (en) (4-Arylsulfonylamino) tetrahydropyran-4-carboxylsyrehydroxamider
ID23458A (en) NEFAZODON AVAILABLE FORM
DE69941870D1 (en) L-SOUND FORMAT
ID23735A (en) TABLET TROVAFLOKSASIN MESILAT
DE69823561D1 (en) inhalers
DE59909297D1 (en) Carbonyleisensilizid powder
FR2763507B1 (en) INHALER
DE69917842D1 (en) INHALATION APPARATUS
DE69921275D1 (en) inhaler
DE69824327D1 (en) inhaler
NO20003182L (en) Powder Inhalation Procedure
DE69937138D1 (en) COMPOSITE POWDER
FR2782671B3 (en) DELIVERED
ID19844A (en) POWDER COMPONENTS
DE59909647D1 (en) tracheal